News

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...
GLP-1 receptor agonists are associated with risk reductions for dozens of diseases and conditions in addition to rapid weight ...
It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...
Claire Reed bought medication online to lose weight before a vacation, but claims she was passing out and too nauseous to eat ...